ResearcherPeking University First HospitalActive in the last 2 years

Rui Ma

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0188-5499; OpenAlex author ID A5100710180. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2025: 1 paper

Papers 1

Current status and future prospects of cancer-derived immunoglobulins in pancreatic cancer. Co-author DOI 10.7150/jca.109497 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xiaodong Tian · 1 shared paper, 2025 · strength 0.26
- Paper Current status and future prospects of cancer-derived immunoglobulins in pancreatic cancer. DOI 10.7150/jca.109497 ↗
Yongsu Ma · 1 shared paper, 2025 · strength 0.26
- Paper Current status and future prospects of cancer-derived immunoglobulins in pancreatic cancer. DOI 10.7150/jca.109497 ↗
Yinmo Yang · 1 shared paper, 2025 · strength 0.26
- Paper Current status and future prospects of cancer-derived immunoglobulins in pancreatic cancer. DOI 10.7150/jca.109497 ↗
Yiran Chen · 1 shared paper, 2025 · strength 0.26
- Paper Current status and future prospects of cancer-derived immunoglobulins in pancreatic cancer. DOI 10.7150/jca.109497 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.